Type 2 & other diabetes

SGLT2 Inhibitors and Nephrolithiasis Risk in Adults With Type 2 Diabetes: A Systematic Review and Meta-analysis

Endocr PractPublished Systematic review and meta-analysis

Pooled result · NephrolithiasisResult — go to the resultOdds ratio 0.72 95% CI 0.65–0.80

Authors' conclusion

SGLT2i were associated with lower odds of nephrolithiasis in adults with type 2 diabetes. Substantial heterogeneity and the largely observational evidence base limit causal interpretation.

Study context

Population
Adults with T2D; comparative studies of SGLT2i (PubMed, Embase, CENTRAL through April 26, 2026)10 studies · 14 comparisons
Comparison
SGLT2i vs comparators
Outcome
Nephrolithiasis
Methodological detailsrandom-effects (restricted maximum likelihood), subgroup analyses, meta-regression
  • Random-effects (restricted maximum likelihood)
  • Subgroup analyses
  • Meta-regression

Pooled result

As reported in the abstract

Odds ratio

0.72

95% CI 0.65–0.80

P < 0.001

SGLT2ivs All comparators
OR 0.72 (95% CI 0.65–0.80); P < 0.001

Further pooled results

OutcomeOR (95% CI)
Nephrolithiasis by comparatorSGLT2ivs Non-user controls0.55 (0.52–0.58)
Nephrolithiasis by comparatorSGLT2ivs Placebo0.65 (0.49–0.85)
Nephrolithiasis by comparatorSGLT2ivs DPP-4i0.74 (0.63–0.86)
Nephrolithiasis by comparatorSGLT2ivs GLP-1 RA0.79 (0.70–0.90)
Nephrolithiasis by comparator — Subgroup difference by comparator
p for subgroup difference < 0.0001

Effect modifiers

Comparator class accounted for between-comparison variability; moderator test not significant
29.5% (p = 0.10)
Associations consistent across study designs; outcome ascertainment methods did not significantly modify the association
Follow-up duration not significantly associated with effect size

Original publication

SGLT2 Inhibitors and Nephrolithiasis Risk in Adults With Type 2 Diabetes: A Systematic Review and Meta-analysis. Endocr Pract. Published 29 September 2026. doi:10.1016/j.eprac.2026.09.007

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.